XML 28 R35.htm IDEA: XBRL DOCUMENT v2.4.0.8
Supplemental Cash Flow Disclosures - Supplemental Cash Flow Disclosures (Details) (USD $)
3 Months Ended 12 Months Ended 85 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2012
Mar. 31, 2014
Supplemental disclosure of cash flow information:        
Cash paid for interest expense         $ 3,660
Cash paid for income taxes           
Noncash operating and financing activities:        
Due to Organetix, Inc. reclassified to additional paid-in capital         91,500
Common stock to satisfy minimum value guarantee         87,667
Common stock issued to satisfy debt 56,929   76,528 133,187
Convertible debt converted and accrued interest to common stock 271,352   259,986 1,509,600
Common stock issued in exchange for fixed assets       7,420 7,420
Common stock issued in conjunction with joint venture      $ 9,800 $ 9,800